These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 18187434

  • 1. Probiotics in irritable bowel syndrome: an immunomodulatory strategy?
    Quigley EM.
    J Am Coll Nutr; 2007 Dec; 26(6):684S-90S. PubMed ID: 18187434
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of probiotics in IBS.
    Quigley EM.
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
    [Abstract] [Full Text] [Related]

  • 3. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM, Flourie B.
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [Abstract] [Full Text] [Related]

  • 4. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM.
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [Abstract] [Full Text] [Related]

  • 5. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M.
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [Abstract] [Full Text] [Related]

  • 6. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC, Sanderson JD, Whelan K.
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [Abstract] [Full Text] [Related]

  • 7. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 8. Inflammation and microflora.
    Pimentel M, Chang C.
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [Abstract] [Full Text] [Related]

  • 9. Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets.
    Dahlqvist G, Piessevaux H.
    Acta Gastroenterol Belg; 2011 Sep; 74(3):375-80. PubMed ID: 22103040
    [Abstract] [Full Text] [Related]

  • 10. The role of probiotics in management of irritable bowel syndrome.
    Borowiec AM, Fedorak RN.
    Curr Gastroenterol Rep; 2007 Oct; 9(5):393-400. PubMed ID: 17991340
    [Abstract] [Full Text] [Related]

  • 11. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 13. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J, Brummer RJ.
    Benef Microbes; 2014 Sep 14; 5(3):247-61. PubMed ID: 24583610
    [Abstract] [Full Text] [Related]

  • 14. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL.
    Aliment Pharmacol Ther; 2014 May 14; 39(10):1033-42. PubMed ID: 24665829
    [Abstract] [Full Text] [Related]

  • 15. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence.
    Quigley EM.
    J Clin Gastroenterol; 2015 May 14; 49 Suppl 1():S60-4. PubMed ID: 26447967
    [Abstract] [Full Text] [Related]

  • 16. The use of probiotics in IBD and IBS.
    De Greef E, Vandenplas Y, Hauser B, Devreker T, Veereman G.
    Minerva Pediatr; 2014 Oct 14; 66(5):491-500. PubMed ID: 25243502
    [Abstract] [Full Text] [Related]

  • 17. Probiotics in gastrointestinal disorders.
    Quigley EM.
    Hosp Pract (1995); 2010 Nov 14; 38(4):122-9. PubMed ID: 21068536
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC, Brostoff J, Whelan K, Sanderson JD.
    Am J Gastroenterol; 2008 Jun 14; 103(6):1557-67. PubMed ID: 18513268
    [Abstract] [Full Text] [Related]

  • 19. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K, Quigley EM.
    Curr Opin Gastroenterol; 2013 Mar 14; 29(2):184-9. PubMed ID: 23286925
    [Abstract] [Full Text] [Related]

  • 20. What is the evidence for the use of probiotics in functional disorders?
    Quigley EM.
    Curr Gastroenterol Rep; 2008 Aug 14; 10(4):379-84. PubMed ID: 18627649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.